SCHEMBL20151838

SCHEMBL20151838

CCOC(=O)CCCN(Cc1ccc(OC)cc1)c1cc(C)ccc1C=O

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARG P37231 1/20 0.39
ALDH1A1 P00352 4/20 0.39
HSD17B10 Q99714 2/20 0.39
USP2 O75604 1/20 0.39
GAA P10253 1/20 0.39
ALOX15 P16050 1/20 0.39
MAPK1 P28482 1/20 0.39
CASP1 P29466 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
BCHE P06276 2/20 0.38
L3MBTL1 Q9Y468 2/20 0.38
ACHE P22303 1/20 0.38
LMNA P02545 1/20 0.38
MAPT P10636 1/20 0.38
LTA4H P09960 4/20 0.38
TSPO P30536 1/20 0.38
KDM4E B2RXH2 2/20 0.37
TSHR P16473 2/20 0.37
PDE3B Q13370 1/20 0.37
PDE3A Q14432 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20150068 0.88 TSPO (0.39) ALDH1A1HSD17B10USP2GAABCHE
SCHEMBL20137115 0.88 LTB4R2 (0.44) PPARGBCHEACHEMAPT
SCHEMBL20151846 0.78 PPARD (0.38) ALDH1A1HSD17B10MAPK1L3MBTL1LMNA
SCHEMBL20137405 0.78 BCL2A1 (0.38) ALDH1A1BCHEACHEMEN1KMT2A
SCHEMBL28880216 0.78 BCL2A1 (0.41) PPARGUSP2L3MBTL1TSHRMEN1
SCHEMBL20151844 0.78 ALOX5 (0.37) PPARGALDH1A1HSD17B10MAPK1L3MBTL1
SCHEMBL20151842 0.77 PPARD (0.36) ALDH1A1MAPK1L3MBTL1MAPTTSPO
SCHEMBL20137411 0.76 LTB4R2 (0.40) BCHEMAPT
SCHEMBL20570505 0.75 LTB4R2 (0.42) PPARGUSP2TSHR
SCHEMBL3459748 0.74 BCHE (0.41) ALDH1A1MAPK1BCHEACHEMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180134674-A1 MAGL INHIBITORS H. LUNDBECK A/S (DK) 2018-05-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180134674-A1 MAGL INHIBITORS MAG, MAGI3, MGLL PPARG 2047/4885ALDH1A1 4349/4885HSD17B10 4690/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.